The Implementation of a Trans-tailored Harm Reduction Service for Transgender Persons in Relation to chemsEX and Substance Use (iT-REX)

Recruiting now · Not applicable

Conditions studied: HIV Prevention, Substance Use, Mental Health Disorders, Sexually Transmitted Infections (STIs), Chemsex

In brief

This study evaluates a comprehensive transgender-tailored harm reduction service for transgender women, transgender men, and non-binary individuals engaging in chemsex or substance use in Thailand, focusing on PrEP uptake, HIV/STI outcomes, mental health, and socio-legal impacts.

Key facts

Study ID

NCT07512856

Run by

Institute of HIV Research and Innovation Foundation, Thailand

People needed

140

Starts

2024-02-01

Expected to finish

2028-02-01

Last updated by the study team

2026-04-06

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Self-identified transgender women, transgender men, or non-binary persons
• Age ≥18 years
• HIV-negative
• Engaged in chemsex or substance use within past 12 months
• Able to provide informed consent

You may not qualify if…

• Inability to communicate in Thai sufficiently to complete study procedures

Where it is running

• Tangerine Clinic, Institute of HIV Research and Innovation — Pathum Wan, Bangkok, Thailand (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.